Agenus (AGEN) Return on Capital Employed [ROCE] (2011 - 2025)
Agenus' Return on Capital Employed [ROCE] was -2045.90% in Q1 2025, down 1573.54 percentage points from -472.36% a year earlier and down 948.23 percentage points from the prior quarter.
Powered by 
Analysis
Agenus (AGEN) Return on Capital Employed [ROCE] (2011 - 2025) Analysis & Trends
For FY2024, Return on Capital Employed [ROCE] at Agenus came in at -247.43%, down 99.47 percentage points from FY2023.
- Return on Capital Employed [ROCE] has now declined for three consecutive years, though with a five-year change of +49.02 percentage points (FY2019 to FY2024).
- In earlier years, Return on Capital Employed [ROCE] was -147.95% in FY2023 (-76.41 pp), -71.54% in FY2022 (-85.59 pp), 14.05% in FY2021 (+227.04 pp) and -213.00% in FY2020 (+83.45 pp).
- Quarterly Return on Capital Employed [ROCE] has moved between -2973.49% (Q2 2024) and 35.23% (Q3 2021) over five years.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2022 (a gain of 384.73 percentage points); the worst was Q2 2024 (a drop of 2866.15 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Agenus | 356.27 Mn | 349.49 Mn | 34.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -2,045.90% |
| Dec 31, 2024 | -1,097.67% |
| Jun 30, 2024 | -2,973.49% |
| Mar 31, 2024 | -472.36% |
| Dec 31, 2023 | -231.92% |
| Sep 30, 2023 | -132.22% |
| Jun 30, 2023 | -107.34% |
| Mar 31, 2023 | -89.20% |
| Dec 31, 2022 | -77.23% |
| Sep 30, 2022 | -65.19% |
| Jun 30, 2022 | 18.51% |
| Mar 31, 2022 | 10.89% |
| Dec 31, 2021 | 8.73% |
| Sep 30, 2021 | 35.23% |
| Jun 30, 2021 | -366.23% |
| Mar 31, 2021 | -151.89% |
| Dec 31, 2020 | -147.25% |
| Sep 30, 2020 | -237.99% |
| Jun 30, 2020 | -285.23% |
| Mar 31, 2020 | -306.81% |
API Access
Agenus Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "AGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();